TheraRadar
← Back
Data updated: Mar 29, 2026

MALLINCKRODT HOSP

GastroenterologyImmunologyRespiratory
Pharma

MALLINCKRODT HOSP is a pharmaceutical company focused on Gastroenterology, Immunology, Respiratory.

2010
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 67%
0 drugs Phase 3: 1 Phase 2: 1
Immunology 22%
0 drugs Phase 1: 2
Respiratory 11%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Immunology, Gastroenterology
Gilead Sciences biotech
Immunology, Gastroenterology, Respiratory
Novartis big-pharma
Immunology, Respiratory
MALLINCKRODT specialty
Gastroenterology, Immunology, Respiratory
LEGACY PHARMA big-pharma
Respiratory, Gastroenterology, Immunology